国产免费人成在线视频,国产亚洲精品美女久久久m,久久久综合九色合综国产精品,一本久久a久久免费不卡

      <i id="xqvzo"></i>

        <i id="xqvzo"></i>

        <acronym id="xqvzo"><bdo id="xqvzo"></bdo></acronym>
        Lean Manufacturing
        Home Manufacturing

        Lean Manufacturing

        Lean Manufacturing

        Our company has always been dynamically consistent with the global advanced access level by continuously designing and building production facilities and lines in accordance with international advanced standards and using advanced production equipment. Our company’s product quality system has been officially certified by US FDA, EU EMA and Japan PMDA.

        Production Base
        • 3 manufacturing sites
          Integration of pharmaceutical intermediates, APIs, and Formulations
        • Finished Production - 191000 m²
          API production - 290000 m²
        • Officially certified by China NMPA,
          US FDA, EU EMA and Japan PMDA.
        Frontier base for pharmaceutical industry, Creating world-class production standards

        Hansoh Pharmaceuticals Production Base (Lianyungang) has two finished production sites and one API production site.

        Jiangsu Hansoh Pharmaceuticals Production Base – Finished Products site

        It has a total area of 191,000 m2. Our company always adheres to the access level consistent with the world's leading productions and insists on designing and building production lines according to international advanced standards. In this site, our company has built 18 finished product workshops, and the products cover a number of production dosage forms such as tablets, capsules, orally dissolved films, injections (in bottles, or soft bags, or vials), lyophilized powder (in pre-filling syringes or cassette bottles). The annual production capacity is about 5 billion tablets of solid formulations and 80 million bottles of injections. 

        精益制造
        精益制造
        精益制造
        精益制造
        精益制造
        Jiangsu Hansoh Pharmaceuticals Production Base - API site

        It covers an area of 290,000 m2 and has a construction area of 143,000 m2. In this site, our company has built 31 API production workshops, and the products cover APIs (including oncology drugs), sterile APIs and psychotropic drugs. 54 varieties have been listed, with an annual production capacity of about 100 tons.

         

        While continuously expanding the production capacity, our company implements the integration of informatization and industrialization, improves the intelligent manufacturing level, and configures digital production and testing equipment. For the existing plant facilities and equipment, our company continues to transform and upgrade, so that the production process changes from unit  operation to continuous line operation, to improve production efficiency; for new workshops and new equipment, advanced production lines at home and abroad are adopted. The workshop gives priority to closed production equipment to reduce safety risks.